Form 4 for MDXH MDxHealth SA

Accepted 2026-08-17 16:05:06 ET · period of report 2026-08-13 · accession 0001193125-26-354021 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
I	2026-08-17 16:05	2026-08-13	MDXH	MVM Partners, LLC	Dir	P - Purchase	$0.454	+2.20M	6.90M	+47%	+$1000.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2026-08-13	P	A	2,202,643	$0.454	6,903,100	I See Footnote	—	—	(F1) Ordinary shares, no par value, of MDxHealth SA (the "Issuer") purchased pursuant to securities purchase agreements by and between the Issuer and certain private investment vehicles managed by MVM Partners, LLC (the "Funds"), each dated as of August 11, 2026. (F2) The securities reported herein are directly owned by the Funds. The securities may also be deemed beneficially owned by MVM Partners, LLC ("MVM") as the investment manager of the Funds and by Eric Bednarski as Managing Member of MVM. Each of Mr. Bednarski and MVM disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interests therein, if any, and this Form 4 shall not be deemed an admission that either Mr. Bednarski or MVM is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.